Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment. (4th November 2015) - Kansy, Benjamin A; Lin, Yan; Ding, Fei; Gibson, Sandra Poveda; Jie, Hyun-Bae; Ferris, Robert L